Related Experiment Video

Updated: Jun 6, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Surgery and mesothelioma: if not randomization, at least standardization and registration!

Harvey Pass

    Lung Cancer (Amsterdam, Netherlands)
    |November 13, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
    07:54

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

    Published on: December 21, 2019

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
    09:31

    Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

    Published on: October 2, 2015

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
    07:54

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

    Published on: December 21, 2019

    Related Concept Videos

    Randomized Experiments01:13

    Randomized Experiments

    The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
    Simple randomization
    Simple...

    Articles linked to this work by shared authors, journal, and citation graph.

    Proteomic, transcriptomic, and metabolic mediators of postcardiopulmonary bypass vasoplegia syndrome.

    The Journal of thoracic and cardiovascular surgery·2026

    Aging Associated Transcriptomic Signatures in Tumor and Tumor Adjacent Lung Tissues Associated with Recurrence Following Resection of Stage I Lung Adenocarcinoma.

    Research square·2026

    Characterizing the Immune Response in Pig-to-Human Heart Xenografts Using a Multimodal Diagnostic System.

    Circulation·2025

    Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinoma.

    bioRxiv : the preprint server for biology·2025

    A Phase I Dose-Escalation Clinical Trial of Bronchoscopic Cryoimmunotherapy in Advanced-Stage NSCLC.

    JTO clinical and research reports·2025

    Microbial biomarker development for detection and prognosis of early-stage non-small cell lung cancer.

    Cancer biomarkers : section A of Disease markers·2025

    Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage Ⅲ non-small cell lung cancer: a single-center retrospective study.

    Lung cancer (Amsterdam, Netherlands)·2026

    Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.

    Lung cancer (Amsterdam, Netherlands)·2026

    Distinct spatial immune microenvironment features of different EGFR mutation subtypes in early-stage lung adenocarcinoma.

    Lung cancer (Amsterdam, Netherlands)·2026

    A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.

    Lung cancer (Amsterdam, Netherlands)·2026

    Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling.

    Lung cancer (Amsterdam, Netherlands)·2026

    Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study.

    Lung cancer (Amsterdam, Netherlands)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us